Core Viewpoint - The inclusion of cochlear implants in the medical insurance payment policy is a significant breakthrough for patients with severe hearing loss in China, potentially benefiting around 6 million individuals who previously could not afford the high costs of these devices [1][2]. Group 1: Patient Impact - An estimated 600 million people in China suffer from severe hearing loss, with many unable to afford cochlear implants priced at approximately 300,000 yuan [2]. - The new policy will reduce personal expenses for cochlear implants by 90%, allowing patients to pay around 20,000 yuan to regain their hearing [1][4]. - Currently, only 130,000 patients have received cochlear implants nationwide, indicating a significant gap between need and access due to financial constraints [3]. Group 2: Policy Changes - The Jiangsu provincial government has implemented a new policy that includes cochlear implants in the medical insurance reimbursement system, which will take effect on December 1 [1][4]. - The price of cochlear implants has decreased significantly from 200,000-300,000 yuan to approximately 50,000 yuan, with patients now only responsible for 20,000-30,000 yuan [4]. - This policy expansion not only covers children but also extends benefits to all age groups, enhancing access to cochlear implants for a broader population [4]. Group 3: Clinical and Social Implications - The policy change is expected to improve the quality of life for many, including elderly patients who have historically had low intervention rates for age-related hearing loss [5]. - Successful cases of cochlear implant surgeries have been reported, with over 2,000 children benefiting from government subsidies at Nanjing Gulou Hospital [5]. - The implementation of this policy is anticipated to lead to better training for medical professionals, ensuring safer and more efficient procedures for cochlear implant surgeries [6].